Iron Deficiency Anemia of Pregnancy Clinical Trial
Official title:
Lactoferrin Versus Ferrous Fumarate for Treatment of Mild to Moderate Iron Deficiency Anemia During Pregnancy
This study will conducted to evaluate and comparison between the effectiveness, safety and acceptability of lactoferrin alone, ferrous fumarate alone and combination of both for the treatment of mild to moderate IDA during pregnancy.
Anemia in pregnancy is a major public health problem, where it has been estimated that 41.8%
of pregnant women worldwide are anemic .
Iron deficiency anemia (IDA) is the condition in which there is anemia due to a lack of iron.
IDA develops when available iron is insufficient to support normal red cell production and is
the most common type of anemia Anemia has a significant impact on the health of the fetus as
well as that of the mother. It impairs the oxygen delivery through the placenta to the fetus
and interferes with the normal intrauterine growth, leading to fetal loss and perinatal
deaths. Anemia is associated with increased preterm labor (28.2%), preeclampsia (31.2%), and
maternal sepsis.
The daily requirement of iron is around 1.5 mg in nonpregnant women. This requirement
increases dramatically during pregnancy to reach 6-7 mg/day (total 1000 mg) with advanced
gestational age. Pregnancy causes a twofold to threefold increase in the requirement for iron
and a 10- to 20-fold increase in folate requirement. The increase in demand for iron is
mainly due to fetal requirement, placenta, blood volume, tissue accretion, and the
intra-partum potential for blood loss
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03456258 -
Lactoferrin Versus Ferrous Sulphate for the Treatment of Iron Deficiency Anemia During Pregnancy
|
N/A | |
| Not yet recruiting |
NCT04074707 -
Defining a Dosing Regimen With Maximal Absorption for Oral Iron Supplementation During Pregnancy
|
N/A | |
| Completed |
NCT03481790 -
Lactoferrin Versus Ferrous Sulphate for Treatment of Iron Deficiency Anaemia During Pregnancy
|
Phase 2 | |
| Terminated |
NCT04594070 -
Daily Versus Alternate Day Iron Supplementation for the Treatment of Iron Deficiency Anemia in Pregnancy
|
Phase 4 | |
| Completed |
NCT03706638 -
Daily vs Intermittent Iron Therapy in Pregnancy
|
N/A | |
| Recruiting |
NCT06366698 -
Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia
|
Phase 3 | |
| Recruiting |
NCT03961074 -
Iron Deficiency Anemia Among Chinese Pregnant Women: a Multi-center Prospective Cohort Study
|
||
| Recruiting |
NCT05804071 -
Analysis of the Effect of Iron Supplements on Iron Deficiency Anemia in Pregnancy
|
Phase 4 | |
| Recruiting |
NCT04008147 -
Hepcidin and Glucose Metabolism
|
N/A | |
| Completed |
NCT03188445 -
Intravenous Iron Isomaltoside Versus Oral Iron Supplementation for Treatment of Iron Deficiency in Pregnancy.
|
Phase 4 | |
| Completed |
NCT05157828 -
Iron Deficiency Anaemia in Pregnant Patients Presenting for Antenatal Care
|
||
| Active, not recruiting |
NCT05545527 -
Neuroimaging Ancillary Study
|
||
| Completed |
NCT05725278 -
Impact Evaluation of Triggerise's Tiko Platform
|
N/A | |
| Completed |
NCT03378791 -
Efficacy of Iron Bisglycinate in Treatment of Iron Deficiency Anemia in Pregnant Women
|
Phase 3 | |
| Completed |
NCT02005588 -
Treatment of Iron Deficiency Anemia With Pregnancy
|
Phase 0 | |
| Completed |
NCT03657433 -
Intravenous Infusions of Ferumoxytol Compared to Oral Ferrous Sulfate for the Treatment of Anemia in Pregnancy
|
Phase 3 | |
| Completed |
NCT04976179 -
Iron Infusion Into a Vein Compared to Iron Tablet Taken by Mouth for Treating Iron Deficiency Anemia in Pregnancy (IVON)
|
Phase 3 | |
| Completed |
NCT03438227 -
Intravenous Iron for Iron-deficiency Anemia in Pregnancy: a Randomized Controlled Trial
|
Phase 4 | |
| Available |
NCT05151679 -
Chelated Oral Iron Versus Intravenous Iron Sucrose for Treatment of Iron Deficiency Anemia Late in Pregnancy
|